Company Active LTD

Company profile

Newrotex Limited

Newrotex

Newrotex Limited is a UK company with status active founded in 2019 based in South East England.

CRN
11798939
Founded
2019
Age
7

Overview

Legal name
NEWROTEX LIMITED
Region
South East England
Registered address
WOOD CENTRE FOR INNOVATION STANSFIELD PARK, QUARRY ROAD
HEADINGTON
OXFORD
OXFORDSHIRE
ENGLAND
OX3 8SB
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

5 events
05 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Apr
2027

Accounts due

Accounts Due

Next accounts due date

21 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Jul
2025

Accounts filed

Accounts

Last accounts made up date

31 Jan
2019

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2020
Funded years
2020, 2022, 2024
Age at first award
1 years

Projects

2024 EU-Funded Lead participant

The Oxford Nerve Conduit

1 Jan 2024 to 31 Dec 2026

Awarded
£2,116,469
Total cost £2,116,469

Peripheral Nerve Injury (PNI) refers to damage or crushing of nerves outside of the brain or spinal cord, caused by trauma, surgery or cancer. These nerves are responsible for maintaining muscle control & sensations & their damage leads to loss of sensation, chronic pain & loss of muscle movement, reducing patient's quality of life. When nerves are severe...

2022 Collaborative R&D Lead participant

Feasibility of silk nerve conduits for spinal repair application

1 Sep 2022 to 29 Feb 2024

Awarded
£201,104
Total cost £287,291

Spinal cord injury (SCI) is an overwhelming health condition that causes permanent disabilities and even death. Left untreated the spinal cord is not able to heal itself There are currently no implantable devices for spinal cord nerve injury. Rehabilitation is expensive and has limited success with respect to regaining mobility and improving patient quali...

2020 Study Lead participant

Development of tubular silk conduits for housing nerve-regenerating silk fibres

1 Jun 2020 to 28 Feb 2022

Awarded
£165,757
Total cost £236,795

Damage to peripheral nerves through trauma and cancer surgery results in loss of function and significant morbidity worldwide. There are currently no implantable devices for peripheral nerve injury (PNI) as effective as the gold standard autologous nerve grafts. However, these are expensive to perform, require sacrificial nerves from a donor site in the p...

2020 Feasibility Studies Lead participant

Development of tubular silk conduits for housing nerve-regenerating silk fibres - CRO Usage

1 Jun 2020 to 31 Mar 2021

Awarded
£120,000
Total cost £120,000

no public description

Product types

Collaborative R&D EU-Funded Feasibility Studies Study